下肢动脉介入器材市场：2026-2032年全球预测（按器材类型、手术类型、应用和最终用户划分）

预计到 2025 年，下肢动脉介入器材市场价值将达到 44.9 亿美元，到 2026 年将成长至 47.5 亿美元，到 2032 年将达到 69.3 亿美元，复合年增长率为 6.39%。

关键市场统计数据
基准年 2025	44.9亿美元
预计年份：2026年	47.5亿美元
预测年份 2032	69.3亿美元
复合年增长率 (%)	6.39%

在临床创新、医疗实践变革以及对可证实的卫生经济价值的需求压力下，阐明下肢动脉介入治疗的现状。

下肢动脉介入器材市场正处于人口老化、周边动脉疾病盛行率上升以及手术技术快速创新交会的阶段。旨在恢復和维持四肢血流的器械不仅是医疗技术，也是医院和门诊中心降低截肢率、提高病患生活品质的策略性资产。临床、监管和商业相关人员需要在复杂的环境中权衡手术选择、器械疗效和经济因素。

要认识到，设备技术的快速发展、临床通讯协定的改进以及护理环境的转变正在重塑手术决策和实施的动态。

由于技术进步、临床通讯协定的不断改进以及对优化治疗环境的日益重视，下肢动脉介入治疗领域正经历变革性的变化。改良的动脉粥状硬化斑块切除术系统扩大了病变治疗的范围，能够更精准地进行斑块修整，并减少血管损伤。同时，球囊导管技术（尤其是药物涂层球囊）持续影响着血管再阻塞的治疗，促使临床医师重新评估以往在复杂股腘动脉疾病中优先考虑支架置入的决策流程。

评估2025年关税环境如何促使供应链重组、采购流程审查以及重新关注国内製造业的韧性。

2025年美国关税政策为依赖国际供应链的医疗设备製造商、经销商和医疗服务提供者带来了新的商业性复杂性。关税相关的成本压力迫使製造商重新评估其筹资策略，考虑将关键部件的生产转移到近岸地区，并重新谈判供应商合同，以在不影响质量或合规性的前提下维持单位经济效益。这些调整对医院系统和门诊中心的库存计划和采购週期产生了连锁反应，而这些机构历来优先考虑的是最低库存和可预测的前置作业时间。

分析诸如医疗设备类型、临床环境、手术类型和解剖覆盖范围等细微细分因素，以发现差异化的策略重点。

从器械类型、最终用户、手术类型和应用领域分析，市场呈现出明显的异质性，每个维度都揭示了不同的策略意义。依器械类型划分，市场包括抽吸器械、斑块动脉粥状硬化斑块切除术系统、球囊导管和支架系统。在抽吸器械中，手动和机械系统的普及路径因手术复杂程度和吞吐量需求而异。动脉粥状硬化斑块切除术系统包括定向、雷射、轨道和旋转技术，这些技术在病变适应性和资本密集度方面各不相同。球囊导管分为裸球囊和药物释放型球囊，会影响血管再阻塞的管理策略。支架系统还包括裸金属支架和药物释放型支架，这代表了即时支撑和长期新生内膜控制之间的权衡。

确定区域支付方结构、监管差异和临床偏好如何在全球范围内塑造不同的采用路径和商业模式。

区域趋势对全球临床实务模式和商业策略均有显着影响。在美洲，支付方结构和医院整合趋势促使人们更加关注可验证的临床结果和成本效益，从而影响着大型医院系统和不断扩张的门诊手术领域的产品采纳。该地区的临床医生在做出采购决策时，往往倾向于采用循证工作流程和正式的卫生经济学评估，这反过来又促使製造商透过可靠的真实世界数据和有针对性的培训计画来支持产品推广。

了解创新、伙伴关係和基于证据的价值提案如何重新定义竞争定位和通往商业性成功的道路

主要参与者之间的竞争动态由产品创新、策略联盟以及对实证医学日益重视共同决定。现有市场参与者利用深厚的临床关係和全面的手术产品组合来捍卫其市场份额，而新参与企业则往往在诸如新型动脉粥样动脉粥状硬化斑块切除术机製或下一代药物输送技术等细分领域展开竞争。医疗设备製造商、诊断影像提供者和数位医疗供应商之间的策略联盟正逐渐成为建立整合式手术解决方案的通用途径，这些解决方案旨在应对临床和工作流程方面的挑战。

为製造商和供应商提供切实可行的策略，以协调创新重点、供应链韧性和证据生成，从而实现长期应用。

产业领导者应采取多管齐下的方法，将研发重点与具有临床意义的成果结合，同时提升供应链透明度和商业性弹性。首先，应优先投资于能够显着降低再次手术率和手术併发症的技术，并确保临床开发项目不仅涵盖疗效终点，还应涵盖生活品质和卫生经济学指标。这些数据对于与支付方和系统级采购方沟通至关重要，因为他们越来越需要长期价值的证明。

采用三角调查方法，结合专家访谈、医疗设备审核、监管审查和临床证据综合，得出可靠的研究结果。

本分析所依据的研究结合了定性专家访谈、医疗设备性能审核、监管路径审查以及对临床文献和真实世界证据的系统评估。主要发现来自与介入医师、采购负责人和临床负责人的结构化讨论，他们从操作观点提供了关于器械性能、床边决策因素和培训需求的意见。器械性能审核了抽吸器械、动脉粥状硬化斑块切除术系统、球囊导管和支架系统之间的设计差异，以识别输送性、器械特性以及与辅助性治疗的兼容性方面的趋势。

我们得出结论，以结果为导向的创新、供应链韧性以及与支付方一致的价值策略，对于确保持续的临床和商业性成功至关重要。

总之，下肢动脉介入器材领域的特点是技术快速发展、临床实践经济模式不断变化，以及对可证实的临床价值的需求日益增长。这些因素共同有利于致力于以结果为导向的创新、透明的价值链和快速商业化策略的製造商和医疗系统。随着新型动脉粥状硬化斑块切除术机制、先进的药物输送球囊和不断发展的支架技术被引入临床实践，能否将器械性能转化为患者和医疗系统可衡量的获益，将决定其能否被长期采用。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席体验长观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 下肢动脉介入器材市场（依器材类型划分）

• 吸力装置
  • 手动吸痰装置
  • 机械吸力装置
• 动脉粥状硬化斑块切除术系统
  • 定向斑块动脉粥状硬化斑块切除术
  • 雷射动脉动脉粥状硬化斑块切除术
  • 轨道动脉粥状动脉粥状硬化斑块切除术
  • 旋切动脉粥状硬化斑块切除术
• 球囊导管
  • 熊气球
  • 药物涂层球囊
• 支架系统
  • 裸金属支架
  • 药物释放型支架

9. 下肢动脉介入器材市场（依手术类型划分）

• 动脉粥状硬化斑块切除术术
• 经皮血管成形术
• 支架置入术
• 血栓切除术

第十章 下肢动脉介入器材市场（依应用领域划分）

• 膝下介入治疗
• 股腘动脉介入治疗
• 膝下介入治疗

第十一章 下肢动脉介入器材市场（依最终用户划分）

• 门诊手术中心
• 医院
• 专科诊所

第十二章 下肢动脉介入器材市场（按地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 下肢动脉介入器材市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国下肢动脉介入器材市场

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

15. 美国下肢介入器材市场

第十六章：中国下肢动脉介入器材市场

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Abbott Laboratories
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cook Medical LLC
• Johnson & Johnson
• Koninklijke Philips NV
• Medtronic plc
• MicroPort Scientific Corporation
• Terumo Corporation
• WL Gore & Associates, Inc.

The Lower Limb Artery Interventional Devices Market was valued at USD 4.49 billion in 2025 and is projected to grow to USD 4.75 billion in 2026, with a CAGR of 6.39%, reaching USD 6.93 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 4.49 billion
Estimated Year [2026]	USD 4.75 billion
Forecast Year [2032]	USD 6.93 billion
CAGR (%)	6.39%

Clarifying the modern lower limb artery interventional landscape amid clinical innovation, care site shifts, and pressure for demonstrable health-economic value

The lower limb artery interventional devices landscape sits at the intersection of aging demographics, rising prevalence of peripheral arterial disease, and accelerating procedural innovation. Devices designed to restore and preserve limb perfusion are not only medical technologies but also strategic assets for hospitals and outpatient centers seeking to reduce amputation rates and improve patient quality of life. Stakeholders across clinical, regulatory, and commercial functions are navigating a complex environment where procedural choice, device efficacy, and economic considerations converge.

Recent advances in device materials, imaging guidance, and combination therapies have expanded treatment options across the care continuum. As a result, clinicians are increasingly equipped to tailor interventions-ranging from minimally invasive thrombectomy to targeted atherectomy and drug-delivery strategies-based on lesion morphology and patient comorbidity. Transitioning care into ambulatory surgical centers and specialty clinics has intensified competition among device manufacturers, creating pressure to demonstrate clear clinical differentiation and health-economic benefit. In this context, the industry must balance procedural innovation with evidence generation and scalable commercial models.

Recognizing rapid evolution in device technology, clinical protocols, and care-site migration that are reshaping procedural decision-making and adoption dynamics

The landscape for lower limb artery interventions is undergoing transformative shifts driven by technological refinement, evolving clinical protocols, and a growing emphasis on care-site optimization. Improvements in atherectomy systems have expanded lesion treatability, enabling more precise plaque modification while limiting vessel trauma. Concurrently, balloon catheter technology-particularly drug-coated platforms-continues to influence restenosis management, prompting clinicians to reassess decision trees that previously favored stenting in complex femoropopliteal disease.

Beyond device evolution, the procedural ecosystem is changing. There is an observable migration of straightforward endovascular cases from inpatient hospital settings to ambulatory surgical centers and specialty clinics, where workflow efficiency and cost structure differ markedly. This migration drives demand for devices that combine procedural simplicity with predictable outcomes. Moreover, integration of imaging advances, digital procedural planning, and adjunctive pharmacotherapies is reshaping clinical guidelines and institutional protocols. As a result, manufacturers must not only innovate in product design but also invest in outcomes data and pathway optimization to secure adoption in increasingly cost-sensitive and outcome-oriented care environments.

Assessing how the 2025 tariff environment catalyzed supply chain reconfiguration, procurement scrutiny, and renewed focus on domestic manufacturing resilience

The imposition of tariffs by the United States in 2025 introduced a new dimension of commercial complexity for device manufacturers, distributors, and healthcare providers that rely on transnational supply chains. Tariff-related cost pressures have prompted manufacturers to reassess sourcing strategies, consider nearshoring critical component production, and renegotiate supplier contracts to preserve unit economics without compromising quality or regulatory compliance. These adjustments have had cascading effects on inventory planning and procurement cycles within hospital systems and ambulatory centers that traditionally prioritized lean inventories and predictable lead times.

In practice, organizations facing higher import costs have increased scrutiny of device total cost of ownership, placing renewed emphasis on clinical durability and reintervention rates as measures of value. Payers and procurement teams are responding by tightening contracting terms and seeking structured evidence of downstream savings. Consequently, the tariff environment has elevated the importance of supply chain transparency, dual-source strategies, and investment in domestic manufacturing capacity where feasible. Over time, this environment incentivizes integrated commercial models that align manufacturing footprint with reimbursement realities and clinical performance data, thereby mitigating margin erosion and preserving access to advanced therapies.

Unpacking nuanced segmentation across device types, care settings, procedural classes, and anatomical applications to reveal differentiated strategic priorities

The market demonstrates clear heterogeneity when parsed by device type, end user, procedure type, and application, each dimension revealing distinct strategic implications. Based on device type, the landscape spans aspiration devices, atherectomy systems, balloon catheters, and stent systems; within aspiration devices, manual and mechanical modalities exhibit different adoption curves driven by procedural complexity and throughput needs; atherectomy systems encompass directional, laser, orbital, and rotational technologies that vary in lesion suitability and capital intensity; balloon catheters bifurcate into bare balloon and drug-coated balloon options that influence restenosis management strategies; and stent systems include both bare metal and drug-eluting stents that represent trade-offs between immediate scaffolding and long-term neointimal control.

When considering end users, ambulatory surgical centers, hospitals, and specialty clinics present distinct purchasing behaviors, capital constraints, and procedural volumes that influence product preference and contractual arrangements. Procedure type further nuances the landscape, with atherectomy procedures, percutaneous transluminal angioplasty, stenting procedures, and thrombectomy procedures each requiring tailored device features, operator training, and adjunctive support. Finally, application-level segmentation-below the knee intervention, femoropopliteal intervention, and infrapopliteal intervention-dictates device design priorities such as flexibility, deliverability, and drug-delivery kinetics. Taken together, these segmentation lenses underscore the necessity for manufacturers to develop modular strategies that align product portfolios with specific clinical workflows and purchasing frameworks.

Identifying how regional payer structures, regulatory diversity, and clinical preferences shape differentiated adoption pathways and commercial models globally

Regional dynamics strongly influence both clinical practice patterns and commercial strategies across the global landscape. In the Americas, payer structures and hospital consolidation trends drive emphasis on demonstrable clinical outcomes and cost-effectiveness, shaping adoption in both large hospital systems and an expanding ambulatory surgery segment. Clinicians in this region often favor evidence-based workflows and formal health-economic assessments when making procurement decisions, which in turn encourages manufacturers to support product adoption with robust real-world data and targeted training programs.

In Europe, Middle East & Africa, diverse reimbursement models and regulatory environments create a patchwork of adoption pathways where market entry often requires localized evidence generation and agile distribution strategies. Meanwhile, Asia-Pacific presents a varied picture characterized by rapid technology uptake in certain urban centers alongside cost-sensitive markets that prioritize procedural affordability and supply chain efficiency. Across all regions, cross-border regulatory harmonization efforts, capacity-building initiatives, and localized clinical education remain central to expanding access and aligning product development with regional clinical needs. Consequently, commercial plans must be regionally tailored, balancing scale economics with local clinical and regulatory realities.

Explaining how innovation, partnerships, and evidence-based value propositions are redefining competitive positioning and pathways to commercial success

Competitive dynamics among leading players are defined by a mix of product innovation, strategic partnerships, and an increasing emphasis on evidence generation. Market incumbents leverage deep clinical relationships and comprehensive procedural portfolios to defend share, while newer entrants often compete on niche differentiation such as novel atherectomy mechanisms or next-generation drug-delivery technologies. Strategic collaborations between device firms, imaging providers, and digital health vendors are emerging as a common route to create integrated procedural solutions that address both clinical and workflow challenges.

Beyond product features, companies are investing in outcome-focused value propositions that align with hospital quality metrics and payer priorities. This includes expanded registries, sponsored investigator-initiated trials, and health-economic modeling to quantify the downstream impact of reduced reintervention and limb-salvage rates. Additionally, M&A and alliance activity remains a viable pathway to access complementary technologies or to accelerate geographic expansion. For companies seeking to compete, the combination of clinical evidence, supply chain reliability, and post-market support increasingly determines whether a technology achieves sustained clinical integration and commercial traction.

Presenting actionable strategies for manufacturers and providers to align innovation priorities, supply chain resilience, and evidence generation for long-term adoption

Industry leaders should take a multi-pronged approach that aligns R&D priorities with clinically meaningful outcomes, while simultaneously strengthening supply chain transparency and commercial agility. First, prioritize investments in technologies that demonstrably reduce reintervention rates and procedural complications, and ensure that clinical development programs capture not only efficacy endpoints but also quality-of-life and health-economic measures. These data will be pivotal when engaging payers and system-level purchasers who increasingly require proof of long-term value.

Second, diversify supply chains and invest in dual-source or regional manufacturing capabilities to mitigate tariff and import-risk exposure. This structural resilience should be paired with flexible commercial models that accommodate the procurement preferences of hospitals, ambulatory centers, and specialty clinics. Third, cultivate integrated solutions through partnerships with imaging and digital health providers to streamline workflows and reduce procedural variability. Finally, expand training and post-market surveillance programs to accelerate safe adoption in new care settings and to generate real-world evidence that supports reimbursement negotiations and guideline inclusion.

Describing a triangulated research methodology combining expert interviews, device audits, regulatory reviews, and clinical evidence synthesis for robust insights

The research underpinning this analysis combined qualitative expert interviews, device feature audits, regulatory pathway reviews, and a systematic assessment of clinical literature and real-world evidence. Primary insight was derived from structured discussions with interventionalists, procurement officers, and clinical leaders who shared operational perspectives on device performance, care-site decision drivers, and training requirements. Device feature audits examined design differentiation across aspiration devices, atherectomy systems, balloon catheters, and stent systems to identify trends in deliverability, device profile, and adjunctive therapy compatibility.

Complementing primary research, regulatory pathway reviews and clinical literature syntheses provided context on approval trends, labeling updates, and emergent clinical consensus. Real-world evidence registries and published post-market surveillance studies were evaluated to understand safety and durability signals across key applications such as below the knee, femoropopliteal, and infrapopliteal interventions. Throughout the methodology, findings were triangulated to ensure that commercial and clinical interpretations reflect a balanced view of innovation, procedural adoption, and system-level constraints.

Summarizing the imperative for outcome-driven innovation, supply chain resilience, and payer-aligned value strategies to secure enduring clinical and commercial success

In conclusion, the lower limb artery interventional devices arena is defined by accelerating technological refinement, shifting care-site economics, and heightened demands for demonstrable clinical value. These forces collectively favor manufacturers and health systems that commit to outcome-oriented innovation, transparent supply chains, and responsive commercialization strategies. As clinical practice integrates newer atherectomy mechanisms, advanced drug-delivery balloons, and evolving stent technologies, the ability to translate device performance into measurable patient and system benefits will determine long-term adoption.

Looking ahead, stakeholders who invest in rigorous evidence generation, regional market tailoring, and adaptive operational models will be best positioned to capture opportunity while navigating policy and procurement headwinds. The imperative for coordinated efforts-linking clinical evidence, manufacturing resilience, and payer-aligned value propositions-has never been greater, and organizations that act decisively will more effectively drive improved limb salvage outcomes and durable commercial returns.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Lower Limb Artery Interventional Devices Market, by Device Type

• 8.1. Aspiration Devices
  • 8.1.1. Manual Aspiration
  • 8.1.2. Mechanical Aspiration
• 8.2. Atherectomy Systems
  • 8.2.1. Directional Atherectomy
  • 8.2.2. Laser Atherectomy
  • 8.2.3. Orbital Atherectomy
  • 8.2.4. Rotational Atherectomy
• 8.3. Balloon Catheters
  • 8.3.1. Bare Balloon
  • 8.3.2. Drug-Coated Balloon
• 8.4. Stent Systems
  • 8.4.1. Bare Metal Stent
  • 8.4.2. Drug-Eluting Stent

9. Lower Limb Artery Interventional Devices Market, by Procedure Type

• 9.1. Atherectomy Procedures
• 9.2. Percutaneous Transluminal Angioplasty
• 9.3. Stenting Procedures
• 9.4. Thrombectomy Procedures

10. Lower Limb Artery Interventional Devices Market, by Application

• 10.1. Below The Knee Intervention
• 10.2. Femoropopliteal Intervention
• 10.3. Infrapopliteal Intervention

11. Lower Limb Artery Interventional Devices Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Hospitals
• 11.3. Specialty Clinics

12. Lower Limb Artery Interventional Devices Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Lower Limb Artery Interventional Devices Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Lower Limb Artery Interventional Devices Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Lower Limb Artery Interventional Devices Market

16. China Lower Limb Artery Interventional Devices Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Abbott Laboratories
• 17.6. B. Braun Melsungen AG
• 17.7. Becton, Dickinson and Company
• 17.8. Boston Scientific Corporation
• 17.9. Cook Medical LLC
• 17.10. Johnson & Johnson
• 17.11. Koninklijke Philips N.V.
• 17.12. Medtronic plc
• 17.13. MicroPort Scientific Corporation
• 17.14. Terumo Corporation
• 17.15. W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MANUAL ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MANUAL ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MANUAL ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MECHANICAL ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MECHANICAL ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MECHANICAL ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE BALLOON, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE BALLOON, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-COATED BALLOON, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-COATED BALLOON, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-COATED BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-ELUTING STENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-ELUTING STENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-ELUTING STENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTING PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTING PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTING PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY THROMBECTOMY PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY THROMBECTOMY PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY THROMBECTOMY PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BELOW THE KNEE INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BELOW THE KNEE INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BELOW THE KNEE INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY FEMOROPOPLITEAL INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY FEMOROPOPLITEAL INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY FEMOROPOPLITEAL INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY INFRAPOPLITEAL INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY INFRAPOPLITEAL INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY INFRAPOPLITEAL INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 79. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 80. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 81. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 82. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 83. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 84. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 85. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 86. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 87. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 88. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 89. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 90. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 91. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 92. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 93. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 94. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 95. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 96. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 97. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 98. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 99. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 100. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 101. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 102. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 103. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 104. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 105. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 106. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 107. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 108. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 109. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 116. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 117. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 118. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 119. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 120. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 121. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 122. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 123. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 124. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 125. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 126. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 127. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 128. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 129. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 130. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 131. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 132. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 133. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 134. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 135. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 136. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 137. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 138. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 139. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 140. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 141. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 142. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 143. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 144. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 145. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 146. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 147. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 148. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 149. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 150. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 151. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 152. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 153. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 154. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 155. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 156. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 157. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 158. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 159. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 160. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 161. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 162. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 163. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 164. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 165. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 166. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 167. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 168. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 169. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 170. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 171. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 172. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 173. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 174. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 175. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 176. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 177. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 178. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 179. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 180. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 181. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 182. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 183. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 184. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 185. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 186. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 187. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 188. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 189. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 190. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 191. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 192. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 193. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 194. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 195. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 196. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 197. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 198. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 199. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 200. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 201. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 202. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 203. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 204. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 205. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 206. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 207. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 208. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 209. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 210. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 211. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 212. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 213. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 214. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 215. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 216. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 217. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 218. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 219. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 220. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 221. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 222. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
• TABLE 223. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 224. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
• TABLE 225. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 226. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 227. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 228. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)